Mammoth Biosciences Stock

Developed a CRISPR-based platform for disease to enable the detection of any type of nucleic acid.

Price Per Share $7.14 -36.42%
Updated Nov 06, 2026

Mammoth Biosciences Share Price

You can scroll over the chart's area to move in time and tap to see a specific date.

6 Months 12 Months 24 Months

Highest Bid

$ 260.80

Lowest Offer

$ 188.50

Last Trade

$ 234.00

Live Orders

1,298

View Mammoth Biosciences Market

Buy

Buy Mammoth Biosciences shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Mammoth Biosciences shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Overview

Mammoth Biosciences is a biotechnology company based in Brisbane, California, that focuses on developing diagnostic tests and therapies using advanced CRISPR technology. Mammoth Biosciences aims to leverage its proprietary ultracompact CRISPR systems for various applications, including gene editing and decentralized precision diagnostics.

Sector

Healthcare & Life Sciences

Founded

2017

Headquarters

Brisbane , CA

Mammoth Biosciences Funding

Mammoth Biosciences Funding History

Sign up to gain insights into Mammoth Biosciences funding history, including the funding round, time period, and amount raised.

Financing Round Date Amount Price per share Valuation
Round Date Amount PPS Valuation
Series D-2 Apr 22, 2024 107M
XXXXX
XXXXX
Series D Aug 05, 2021 150M
XXXXX
XXXXX
Series C May 19, 2020 44M
XXXXX
XXXXX
Series C-1 May 19, 2020 748K
XXXXX
XXXXX
Series B Feb 24, 2020 37M
XXXXX
XXXXX
Series B-1 Feb 24, 2020 7M
XXXXX
XXXXX
Series A Feb 25, 2019 5M
XXXXX
XXXXX
Series A May 15, 2018 13M
XXXXX
XXXXX

Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market

Buy

Buy Mammoth Biosciences shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Mammoth Biosciences shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Mammoth Biosciences Management Team

Mammoth Biosciences people and management

  • Co-Founder, CEO, Board Member
    Trevor Martin
  • Co-Founder, CTO, Board Member
    Janice Chen
  • Co-Founder
    Jennifer A. Doudna
  • Co-Founder, Chief Science Officer
    Lucas Harrington
  • CFO, COO
    Elain Sun
  • CSO, Chief Business Officer
    Phil Tinmouth
  • Board Member
    Jeff Huber
  • Board Member
    Jeremy Green
  • Board Member
    Maneesh Jain
  • Board Member
    Min Cui

Investors

Major Mammoth Biosciences investors

  • 8VC

  • Amazon

  • Amoon

  • aMoon Fund

  • Brook Byers

  • Decheng Capital

  • Decheng Capital LLC

  • Foresite Capital

  • Greenspring Associates

  • Individuals

  • Mayfield

  • Nfx

  • NFX

  • Pacific 8

  • Pacific 8 Ventures

  • Plum Alley Co.

  • Plum Alley Investments

  • Redmile Group

  • Senator Investment Group

  • Sixth Street Partners

  • Verily

  • Verily Life Sciences LLC

Mammoth Biosciences Valuations & Financials

Gain Insights Into Mammoth Biosciences Stock Valuation & Share Prices

View real-time NPM data on Mammoth Biosciences stock including daily Mammoth Biosciences stock price estimates, valuation history, and historical share price information. Access Mammoth Biosciences financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Mammoth Biosciences pricing across six independent market signals. Looking for private company due diligence data sources on Mammoth Biosciences? Get in touch to learn more.

Similar Companies

Explore companies

like Mammoth Biosciences

  • Clarify Health Solutions-Logo

    Clarify

    Healthcare & Life Sciences

    Delivers actionable insights from complex medical data to support better care and operational decisions.

  • Ambience

    Healthcare & Life Sciences

    AI-powered solutions to improve clinical documentation and reduce clinician burnout.

  • Array Behavioral Care

    Healthcare & Life Sciences

    Provider of telepsychiatry and telebehavioral health services.

  • Neuralink-Logo

    Neuralink

    Healthcare & Life Sciences

    Neurotechnology company aiming to create a generalized brain-computer interface (BCI) implant.

  • Joinhonor-Logo

    Honor

    Healthcare & Life Sciences

    Connects people seeking non-medical, in-home personal care for seniors with independent care service providers.

  • Judi Health

    Healthcare & Life Sciences

    Healthcare technology company that manages pharmacy benefits.

  • TripleBar

    Healthcare & Life Sciences

    Creates products that nourish, heal, and sustain both people and the planet.

  • Hone Health

    Healthcare & Life Sciences

    Online clinic specializing in preventative and proactive longevity care.

  • Clear Labs

    Healthcare & Life Sciences

    Pioneers in food analytics, enabling brands to differentiate on quality and ensure value.

FAQ

Questions?

We have answers

Buy Mammoth Biosciences Stock

Mammoth Biosciences stock does not trade on public stock exchanges. Mammoth Biosciences stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Mammoth Biosciences stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Mammoth Biosciences Stock

Mammoth Biosciences Stock does not trade on public stock exchanges. In order to sell Mammoth Biosciences shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

 

Mammoth Biosciences Stock Price

Nasdaq Private Market estimates that Mammoth Biosciences price per share was $7.14 as of November 06, 2026. This Mammoth Biosciences share value estimate (known as the NPM price) is based on market activity, publicly-sourced valuation data, and other proprietary information. With NPM Data and Intelligence premium for investors, you can get visibility into the Mammoth Biosciences share price today and the factors driving Mammoth Biosciences valuation estimates. Learn more about premium data here.

Read more about private company stock prices: Understanding the Bid-Ask Spread: How Buyers and Sellers Match on Price

Mammoth Biosciences Stock Ticker Symbol

There is no ticker symbol for Mammoth Biosciences stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Mammoth Biosciences Stock

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Mammoth Biosciences stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in Mammoth Biosciences Stock

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Mammoth Biosciences stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Mammoth Biosciences Stock Settlement

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Mammoth Biosciences IPO

Mammoth Biosciences is a private company and has not had an IPO. There is currently no Mammoth Biosciences IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Mammoth Biosciences IPO.

Learn more about Data and Intelligence private company stock data for institutional investors on the NPM Data and Intelligence Product Page.